来自Ocrelizumab和Rituximab治疗的中性质衰竭并发症
Venus Pang1, Nabil Seery2, Robb Wesselingh2
1Department of Neuroscience Monash University, Melbourne, Australia.
Multiple sclerosis and related disorders
|December 3, 2023
概括
中性,B细胞耗尽疗法如ocrelizumab和rituximab的罕见并发症,由于感染风险,需要仔细监测和患者咨询. 这一病例系列详细介绍了12名患有这种不良事件的患者.
科学领域:
- 神经免疫学 神经免疫学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 奥克雷利祖马布和利图西马布是用于多发性硬化症 (MS) 和其他自身免疫性疾病的抗CD20单克隆抗体.
- 利图西马布是一种仿制性抗体,早于ocrelizumab,仍然是各种神经炎症和全身疾病的关键治疗方法.
- 中性症是一种罕见但严重的不良事件,与ocrelizumab和rituximab疗法有关.
研究的目的:
- 在接受ocrelizumab或rituximab治疗的患者中,描述中性衰竭的临床参数.
- 分析中性衰竭的严重程度,持续时间和相关感染.
- 为临床管理和患者咨询提供有关B细胞消耗疗法的信息.
主要方法:
- 一个病例系列报告了12名患者在经过ocrelizumab或rituximab治疗后出现了中性缺陷症.
- 分析临床数据,包括中性质衰竭的严重程度,持续时间,住院时间,感染类型和治疗干预措施.
- 对患者结局和从中性质衰竭中恢复的审查.
主要成果:
- 在接受ocrelizumab或rituximab的患者中,中性症是罕见的并发症.
- 病例系列详细介绍了中性质衰竭的临床特征,严重程度和持续时间.
- 相关的感染和必要的治疗方法来恢复计数被记录下来.
结论:
- 在B细胞耗尽治疗后的中性是不可预测的,可能导致严重的感染.
- 对接受ocrelizumab和rituximab的患者来说,持续的血液学监测至关重要.
- 有信息的患者咨询对于管理与这些疗法相关的风险至关重要,特别是在经历了中性质减退后.
更多相关视频
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
168
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
168
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
215
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
215
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
303
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
303
01:25Immunodeficiency Diseases
947
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
947